Ellen F. Binder
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ellen F. Binder has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Daniel B. Williams
From Washington University School of Medicine, St. Louis, Missouri
2 shared publicationsKenneth B. Schechtman
From Washington University School of Medicine, St. Louis, Missouri
2 shared publicationsWendy M. Kohrt
From Washington University School of Medicine, St. Louis, Missouri
2 shared publications- Donna B. Jeffe
Washington University School of Medicine
1 shared publication - J. Philip Miller
Institute for Informatics, Data Science, and Biostatistics (I2DB), Washington University in St. Louis School of Medicine, St. Louis, MO, United States
1 shared publication J. S. Fisher
Division of Geriatrics and Gerontology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110
1 shared publication
Latest Publications
- Open Access
- 1 October 2001
- Published by Oxford University Press (OUP) in The Gerontologist
- Vol. 41 (5) , 671-679
Development of a Test of Physical Performance for the Nursing Home Setting
Purpose: This study was undertaken to develop a performance-based instrument to measure a range of function present among nursing home (NH) residents and to establish the reliability and validity of the measures. Design and Methods: Fourteen items integral to daily life in a NH setting were administered to 95 NH residents with sufficient cognitive ability to follow a one-step command at baseline, 1 week later, and 6 months later. Intraclass correlation coefficients and Cronbach's coefficient alpha were calculated for reliability estimates. The Minimum Data Set (MDS), Katz, and Multidimensional Observational Scale for Elderly Subjects (MOSES) were used to establish concurrent validity. Factor analysis, correlation matrices, and other objective criteria were used for item reduction. Results: Test–retest reliability for items ranged between .73 and .93. Factor analysis and correlations between Nursing Home Physical Performance Test (NHPPT) items and scales with measures of activities of daily living (ADL) suggest that the NHPPT taps aspects of gross motor function (Factor 1) and fine motor coordination and task sequencing (Factor 2) required for ADL function and mobility. The NHPPT may also tap aspects of ADL function and mobility not measured by the MDS (r = –.72–.75), MOSES (r = –.82–.84), or Katz (r = –.75–.77) scales. Effect sizes based on mean change scores were larger for the NHPPT scales (.38–.53) than for the other functional scales (.27–.33). Implications: The NHPPT is a reliable performance-based instrument that discriminates among frail NH residents. Further studies are necessary to assess the value of this instrument for prediction and monitoring of functional status in the NH.
- 1 October 2001
- Published by Oxford University Press (OUP) in The Gerontologist
- Vol. 41 (5) , 671-679
Open AccessDevelopment of a Test of Physical Performance for the Nursing Home Setting
Purpose: This study was undertaken to develop a performance-based instrument to measure a range of function present among nursing home (NH) residents and to establish the reliability and validity of the measures. Design and Methods: Fourteen items integral to daily life in a NH setting were administered to 95 NH residents with sufficient cognitive ability to follow a one-step command at baseline, 1 week later, and 6 months later. Intraclass correlation coefficients and Cronbach's coefficient alpha were calculated for reliability estimates. The Minimum Data Set (MDS), Katz, and Multidimensional Observational Scale for Elderly Subjects (MOSES) were used to establish concurrent validity. Factor analysis, correlation matrices, and other objective criteria were used for item reduction. Results: Test–retest reliability for items ranged between .73 and .93. Factor analysis and correlations between Nursing Home Physical Performance Test (NHPPT) items and scales with measures of activities of daily living (ADL) suggest that the NHPPT taps aspects of gross motor function (Factor 1) and fine motor coordination and task sequencing (Factor 2) required for ADL function and mobility. The NHPPT may also tap aspects of ADL function and mobility not measured by the MDS (r = –.72–.75), MOSES (r = –.82–.84), or Katz (r = –.75–.77) scales. Effect sizes based on mean change scores were larger for the NHPPT scales (.38–.53) than for the other functional scales (.27–.33). Implications: The NHPPT is a reliable performance-based instrument that discriminates among frail NH residents. Further studies are necessary to assess the value of this instrument for prediction and monitoring of functional status in the NH.
- 1 May 2001
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 134 (9_Part_1) , 754-760
Effects of Hormone Replacement Therapy on Serum Lipids in Elderly Women
Coronary heart disease (CHD) is the leading cause of death among older women. In observational studies, the incidence of CHD has been reduced in postmenopausal women who take hormone replacement therapy (HRT). A low serum level of high-density lipoprotein (HDL) cholesterol is one of the risk factors predictive of death from CHD. To determine the effects of HRT on serum lipid and lipoprotein levels in elderly women. Randomized, double-blind, placebo-controlled trial. University research center. 59 sedentary women 75 years of age or older. Participants were assigned to 9 months of oral therapy with placebo or conjugated estrogens, 0.625 mg/d, plus trimonthly medroxyprogesterone acetate, 5 mg/d for 13 days. Serum lipid and lipoprotein levels. After 9 months of treatment, women in the HRT group compared with women in the placebo group had decreased low-density lipoprotein cholesterol levels (mean change [+/-SD], -0.47 +/- 0.69 mmol/L [-18.2 +/- 26.5 mg/dL] vs. -0.06 +/- 0.32 mmol/L [-2.2 +/- 12.2 mg/dL], respectively; between-group difference, 0.41 mmol/L [95% CI, 0.09 to 0.74 mmol/L], 16 mg/dL [95% CI, 3.5 to 28.5 mg/dL]; P = 0.01) and increased HDL cholesterol levels (mean change, 0.21 +/- 0.27 mmol/L [8.1 +/- 10.5 mg/dL] vs. 0.06 +/- 0.11 mmol/L [2.4 +/- 4.3 mg/dL], respectively; between-group difference, 0.15 mmol/L [CI, 0.008 to 0.29 mmol/L], 5.7 mg/dL [CI, 0.8 to 10.6 mg/dL]; P = 0.02). The observed changes were independent of age at menopause onset, baseline lipid values, body weight, waist circumference, percentage body fat, and peak aerobic power. In women 75 years of age or older, HRT improved the lipoprotein profile to the extent observed previously in younger postmenopausal women. Further studies are needed to evaluate whether these effects protect against CHD in this population.
- 1 May 2001
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 134 (9_Part_1) , 754-760
Effects of Hormone Replacement Therapy on Serum Lipids in Elderly Women
Coronary heart disease (CHD) is the leading cause of death among older women. In observational studies, the incidence of CHD has been reduced in postmenopausal women who take hormone replacement therapy (HRT). A low serum level of high-density lipoprotein (HDL) cholesterol is one of the risk factors predictive of death from CHD. To determine the effects of HRT on serum lipid and lipoprotein levels in elderly women. Randomized, double-blind, placebo-controlled trial. University research center. 59 sedentary women 75 years of age or older. Participants were assigned to 9 months of oral therapy with placebo or conjugated estrogens, 0.625 mg/d, plus trimonthly medroxyprogesterone acetate, 5 mg/d for 13 days. Serum lipid and lipoprotein levels. After 9 months of treatment, women in the HRT group compared with women in the placebo group had decreased low-density lipoprotein cholesterol levels (mean change [+/-SD], -0.47 +/- 0.69 mmol/L [-18.2 +/- 26.5 mg/dL] vs. -0.06 +/- 0.32 mmol/L [-2.2 +/- 12.2 mg/dL], respectively; between-group difference, 0.41 mmol/L [95% CI, 0.09 to 0.74 mmol/L], 16 mg/dL [95% CI, 3.5 to 28.5 mg/dL]; P = 0.01) and increased HDL cholesterol levels (mean change, 0.21 +/- 0.27 mmol/L [8.1 +/- 10.5 mg/dL] vs. 0.06 +/- 0.11 mmol/L [2.4 +/- 4.3 mg/dL], respectively; between-group difference, 0.15 mmol/L [CI, 0.008 to 0.29 mmol/L], 5.7 mg/dL [CI, 0.8 to 10.6 mg/dL]; P = 0.02). The observed changes were independent of age at menopause onset, baseline lipid values, body weight, waist circumference, percentage body fat, and peak aerobic power. In women 75 years of age or older, HRT improved the lipoprotein profile to the extent observed previously in younger postmenopausal women. Further studies are needed to evaluate whether these effects protect against CHD in this population.
- Open Access
- 1 November 1999
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 84 (11) , 3886-3895
Suppression of Whole Body and Regional Lipolysis by Insulin: Effects of Obesity and Exercise1
The aim of this study was to evaluate in premenopausal women (six endurance-trained nonobese, six sedentary nonobese, and five sedentary obese) the suppression of whole body and regional lipolysis by insulin. Lipolysis was determined using 2H5-glycerol infusion and microdialysis of sc adipose tissue (AT) during a two-stage[ 6–10 (low; LO) and 12–20 (moderate; MOD) mU/m·min] hyperinsulinemic-euglycemic clamp. Microdialysis probes were positioned in abdominal and femoral sc AT to monitor interstitial glycerol and nutritive blood flow. Basal plasma glycerol was 102 ± 9, 52± 6, and 143 ± 30 μmol/L in endurance-trained nonobese, sedentary nonobese, and sedentary obese, respectively (P < 0.05, sedentary nonobese < endurance-trained nonobese, sedentary obese). The plasma glycerol concentration was decreased (P < 0.05) to a greater extent in endurance-trained nonobese and sedentary nonobese[ both to ∼50% (LO) and ∼45% (MOD) of basal] than in sedentary obese [to 72% (LO) and 63% (MOD) of basal]. The rate of appearance of glycerol was suppressed to 36 ± 7%, 44 ± 10%, and 62 ± 7% of basal during LO in endurance-trained nonobese, sedentary nonobese, and sedentary obese, respectively (P < 0.05, endurance-trained nonobese < sedentary obese), and to 34 ± 3%, 36 ± 5%, and 53 ± 8% of basal during MOD, respectively (P < 0.05, endurance-trained nonobese < sedentary obese). There were no between-group differences in the suppression of lipolysis in abdominal sc AT, as evidenced by similar reductions in dialysate glycerol levels[ all to ∼65% (LO) and ∼55% (MOD) of basal]. Femoral dialysate glycerol was reduced (P < 0.05) more in sedentary nonobese and endurance-trained nonobese (to ∼75% of basal) than in sedentary obese (to 90% of basal) during LO, but to a similar extent (to ∼60% of basal) in all groups during MOD. The results indicate that the sedentary obese women had whole body resistance to the suppression of lipolysis by insulin. Intraabdominal AT may be the site of resistance, as resistance was not evident in abdominal or femoral sc AT.
- 1 November 1999
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 84 (11) , 3886-3895
Open AccessSuppression of Whole Body and Regional Lipolysis by Insulin: Effects of Obesity and Exercise1
The aim of this study was to evaluate in premenopausal women (six endurance-trained nonobese, six sedentary nonobese, and five sedentary obese) the suppression of whole body and regional lipolysis by insulin. Lipolysis was determined using 2H5-glycerol infusion and microdialysis of sc adipose tissue (AT) during a two-stage[ 6–10 (low; LO) and 12–20 (moderate; MOD) mU/m·min] hyperinsulinemic-euglycemic clamp. Microdialysis probes were positioned in abdominal and femoral sc AT to monitor interstitial glycerol and nutritive blood flow. Basal plasma glycerol was 102 ± 9, 52± 6, and 143 ± 30 μmol/L in endurance-trained nonobese, sedentary nonobese, and sedentary obese, respectively (P < 0.05, sedentary nonobese < endurance-trained nonobese, sedentary obese). The plasma glycerol concentration was decreased (P < 0.05) to a greater extent in endurance-trained nonobese and sedentary nonobese[ both to ∼50% (LO) and ∼45% (MOD) of basal] than in sedentary obese [to 72% (LO) and 63% (MOD) of basal]. The rate of appearance of glycerol was suppressed to 36 ± 7%, 44 ± 10%, and 62 ± 7% of basal during LO in endurance-trained nonobese, sedentary nonobese, and sedentary obese, respectively (P < 0.05, endurance-trained nonobese < sedentary obese), and to 34 ± 3%, 36 ± 5%, and 53 ± 8% of basal during MOD, respectively (P < 0.05, endurance-trained nonobese < sedentary obese). There were no between-group differences in the suppression of lipolysis in abdominal sc AT, as evidenced by similar reductions in dialysate glycerol levels[ all to ∼65% (LO) and ∼55% (MOD) of basal]. Femoral dialysate glycerol was reduced (P < 0.05) more in sedentary nonobese and endurance-trained nonobese (to ∼75% of basal) than in sedentary obese (to 90% of basal) during LO, but to a similar extent (to ∼60% of basal) in all groups during MOD. The results indicate that the sedentary obese women had whole body resistance to the suppression of lipolysis by insulin. Intraabdominal AT may be the site of resistance, as resistance was not evident in abdominal or femoral sc AT.